Building Data Quality In Generates Quality Data Out

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-05-15-2020
Volume 2020 eBook
Issue 2
Pages: 4-9

Ensuring the quality of data in process monitoring and control systems starts in process development phases.

Ensuring the quality of data in process monitoring and control systems starts in process development phases. Maintaining data integrity during scale up and technical transfer phases is crucial. Building quality features into data management systems is a recommended strategy.

Read this article in Pharmaceutical Technology’s May 2020 Biologics and Sterile Drug Manufacturing eBook. 

Article Details

Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing, May 2020
May 2020
Pages: 4–9

Citation

When referring to this article, please cite it as C. Challener, “Building Data Quality In Generates Quality Data Out," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2020).

 

Articles in this issue
PTebook0520_PreFilled-Syringes_Main-Image.gif
On Point: Biologics Drive Growth in Pre-Filled Syringes
Screen Shot_225.jpg
Instrumenting Single-Use Processes
Ebook_Contamination Control_225.jpg
Considerations in Contamination Control
Best systems and equipment for contamination control
Ebook_Development_225.jpg
Building Data Quality In Generates Quality Data Out
PTeBook0520_ContaminationCellTherapy_main225.jpg
Detecting Contamination in Cell Therapies
PTeBook0520_SeparationViralVector_main225.jpg
Optimizing Viral Vector Manufacturing for Gene Therapy
PTEebook0520_thermo.jpg
Minimizing Contamination During Biopharma R&D
PTEebook0520_agalloco-1.jpg
Complications in Process Simulation Execution
Recent Videos
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Circio and Certest to Collaborate on LNP Formulations

Feliza Mirasol
November 21st 2024
Article

The companies will collaborate to create and test circVec DNA–LNP formulations for use in potential therapeutic applications.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

EMA’s CHMP Gives Positive Opinion for Use of Lecanemab in Early Alzheimer’s Disease

Felicity Thomas
November 16th 2024
Article

CHMP has granted Eisai Europe and Biogen a positive opinion for the use of their monoclonal antibody therapy in treating early Alzheimer’s disease.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Avantor Sees Future of Opportunities with Growing Development of Next-Gen Biotherapeutics

Feliza Mirasol
November 15th 2024
Article

Executives at Avantor talk about the future of the biopharmaceutical industry and the anticipated impact that a wave of next-generation biotherapeutics will bring.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

MD Anderson Launches Cell Therapy Institute

Susan Haigney
November 11th 2024
Article

The new Institute for Cell Therapy Discovery and Innovation will utilize expertise to develop cell therapies for cancer, autoimmune diseases, and infections.